SEARCH RESULT

Total Matching Records found : 15

Ranbaxy drugs safe says Australian drug regulator

-The Economic Times NEW DELHI: After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe. "At present, there is no evidence that any of the products in the Australian market manufactured by Ranbaxy are of an unacceptable quality or that there is a danger to consumers in Australia," a spokesperson for the Australian Therapeutic Goods Administration (TGA) told ET. The Australian...

More »

Ranbaxy drugs fine, say WHO and UK regulator -Rema Nagarajan

-The Times of India NEW DELHI: In yet another twist to the Ranbaxy scandal, the drug regulatory authority of the UK government has issued a statement clarifying that they have found no evidence of any Ranbaxy product in the UK market having been "of unacceptable quality". Last month, WHO had issued a similar statement. It had said that there was no evidence of any of the Ranbaxy products being of unacceptable...

More »

New bulk drug export norms to comply with EU standards

-The Hindu The Commerce and Industry Ministry, on Thursday, issued new guidelines for pharmaceutical makers to comply with the European Union (EU) Good Manufacturing Practice (GMP) standards. In a statement issued here, the Ministry says such a move will give a boost to pharma exports from India. "India has demonstrated its keenness to meet international requirements for exports of pharmaceutical products yet again by taking timely action for complying with the new...

More »

Plan panel sets $100 bn target for pharma sector by 2020

-PTI The Planning Commission has set a target for the Indian pharmaceutical industry to reach USD 100 billion by 2020 and account for 5 per cent share of the global drug industry in the next five years. According to the final draft for 12th Five Year Plan (2012-17) by the panel, the objective of the sector will be to cross the USD 60 billion mark in 2017, which will be 5 per...

More »

WHO clearance will boost Indian vaccine exports -Aarti Dhar

-The Hindu In a major boost to the country’s private vaccine manufacturing pharmaceutical companies, the World Health Organisation (WHO) has said that India’s national regulatory authority — Central Drugs Standard Control Organisation (CDSCO) — and its affiliated institutions meet the prescribed international standards. India is a major vaccine producer with 12 major vaccine manufacturing facilities. These vaccines are used for the national and international market, reaching nearly 150 countries. Every second child...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close